Menu
20/02/2004
Charity hails potential breakthrough to cancer treatment
Stripping cancer cells of their defences against chemotherapy with a new class of anti-resistance drug has the potential to improve treatment for many solid tumours, Cancer Research UK scientists have said.
Cancer cells often resist the effects of treatment with the help of a molecule called P-glycoprotein, which acts as a molecular bouncer – throwing out anti-cancer drugs before they get a chance to take action. But in a study published in the March edition of the European Journal of Cancer, researchers in Oxford have stated that they were able to inactivate the ejection mechanism, making cancer cells vulnerable to treatment.
Scientists knew that a drug called XR9576 could block P-glycoprotein and sensitise individual cancer cells to chemotherapy, but they did not know if the drug would be successful against whole tumours, which can be very difficult to treat.
Professor Robert Souhami, Cancer Research UK, Director of Clinical and External Affairs, said: "It's very upsetting when a patient whose tumour initially seemed to be responding to chemotherapy then begins to relapse as cells become resistant to treatment.
"Cancer cells use a number of strategies for avoiding the effects of chemotherapy, but we can develop methods to overcome them. The new study has demonstrated that by overpowering one of the molecular doormen that many cancer cells employ, it is possible to leave tumours vulnerable to treatment once more. This has obvious potential implications for treatment."
In tests the anti-resistance drugs managed to keep cancer at bay for several years, and some of the most progressive cancers were stalled for several months using the therapy.
Doctor have given the research a cautious welcome.
(gmcg)
Cancer cells often resist the effects of treatment with the help of a molecule called P-glycoprotein, which acts as a molecular bouncer – throwing out anti-cancer drugs before they get a chance to take action. But in a study published in the March edition of the European Journal of Cancer, researchers in Oxford have stated that they were able to inactivate the ejection mechanism, making cancer cells vulnerable to treatment.
Scientists knew that a drug called XR9576 could block P-glycoprotein and sensitise individual cancer cells to chemotherapy, but they did not know if the drug would be successful against whole tumours, which can be very difficult to treat.
Professor Robert Souhami, Cancer Research UK, Director of Clinical and External Affairs, said: "It's very upsetting when a patient whose tumour initially seemed to be responding to chemotherapy then begins to relapse as cells become resistant to treatment.
"Cancer cells use a number of strategies for avoiding the effects of chemotherapy, but we can develop methods to overcome them. The new study has demonstrated that by overpowering one of the molecular doormen that many cancer cells employ, it is possible to leave tumours vulnerable to treatment once more. This has obvious potential implications for treatment."
In tests the anti-resistance drugs managed to keep cancer at bay for several years, and some of the most progressive cancers were stalled for several months using the therapy.
Doctor have given the research a cautious welcome.
(gmcg)
Related UK National News Stories
Click here for the latest headlines.
17 June 2005
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
New drug raises hope of cancer treatment
A prototype cancer drug, which could help fight a range of cancers, has shown “promising results” in clinical trials. Scientists from the Institute of Cancer Research found that the 17AAG drug selectively and potently blocked the growth of a wide range of common cancer cells.
24 May 2005
Trials for prostate cancer drugs announced
Scientists have announced that they are testing new drugs that could be used to treat advanced prostate cancer. Currently, advanced prostate cancer is treated with hormone therapy. However, this only works for a short period of time, after which there are few other options for the patient, apart from palliative care.
Trials for prostate cancer drugs announced
Scientists have announced that they are testing new drugs that could be used to treat advanced prostate cancer. Currently, advanced prostate cancer is treated with hormone therapy. However, this only works for a short period of time, after which there are few other options for the patient, apart from palliative care.
26 September 2003
Genetic testing could assist in cancer treatment, report claims
Testing tumours for the breast cancer gene BRCA1 could be a powerful way of predicting how patients will respond to chemotherapy, scientists from Breast Cancer Campaign and Cancer Research UK have said. Researchers have found that tumour cells react differently to chemotherapy depending on how well BRCA1 is working within them.
Genetic testing could assist in cancer treatment, report claims
Testing tumours for the breast cancer gene BRCA1 could be a powerful way of predicting how patients will respond to chemotherapy, scientists from Breast Cancer Campaign and Cancer Research UK have said. Researchers have found that tumour cells react differently to chemotherapy depending on how well BRCA1 is working within them.
25 March 2014
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
16 November 2005
Alcohol contributing to mouth cancer rise, report claims
Alcohol is contributing to a rise in mouth cancer cases in the UK, but few people are aware that it is a risk factor for the disease, a survey has warned. Cancer Research UK said that cases of mouth cancer have risen by a quarter over the past ten years – from 3,411 in 1992 to 4,285 in 2001.
Alcohol contributing to mouth cancer rise, report claims
Alcohol is contributing to a rise in mouth cancer cases in the UK, but few people are aware that it is a risk factor for the disease, a survey has warned. Cancer Research UK said that cases of mouth cancer have risen by a quarter over the past ten years – from 3,411 in 1992 to 4,285 in 2001.
-
Northern Ireland WeatherThis Evening and Tonight:A fine end to the day with some evening sunshine. It remains mainly dry overnight with a touch of frost or fog patches possible in places. However, cloud is expected to increase towards dawn with the odd light shower. Minimum temperature 2 °C.
